T2 Biosystems Inc.
(TTOO)
undefined
undefined%
At close: undefined
0.40
8.97%
After-hours Dec 13, 2024, 07:59 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 7.19M | 22.30M | 28.06M | 18.13M | 8.34M | 10.50M | 4.67M | 4.08M | 2.81M | 119.00K | 266.00K | 19.00K |
Cost of Revenue | 15.36M | 21.14M | 20.70M | 21.28M | 16.76M | 15.40M | 12.03M | 6.87M | 1.74M | 19.78M | 14.94M | 11.73M |
Gross Profit | -8.17M | 1.17M | 7.36M | -3.15M | -8.43M | -4.90M | -7.36M | -2.79M | 1.07M | -19.66M | -14.67M | -11.71M |
Operating Income | -49.66M | -55.51M | -42.97M | -41.36M | -52.06M | -45.09M | -53.85M | -50.88M | -43.38M | -30.68M | -19.69M | -14.65M |
Interest Income | - | 8.00K | 112.00K | 14.00K | 1K | - | - | - | - | - | - | - |
Pretax Income | -50.08M | -62.32M | -49.24M | -46.80M | -59.01M | -51.15M | -62.43M | -54.80M | -45.29M | -31.39M | -20.61M | -14.46M |
Net Income | -50.08M | -63.37M | -53.49M | -49.21M | -63.11M | -51.15M | -62.43M | -54.80M | -45.29M | -31.39M | -20.61M | -14.46M |
Selling & General & Admin | 24.83M | 30.74M | 28.53M | 21.29M | 27.30M | 25.70M | 22.76M | 24.08M | 19.09M | 11.02M | 5.02M | 2.94M |
Research & Development | 14.15M | 25.93M | 21.80M | 16.92M | 16.33M | 14.49M | 23.73M | 24.01M | 25.36M | 19.78M | 14.94M | 11.73M |
Other Expenses | 2.51M | 31.00K | 206.00K | 62.00K | 400.00K | 619.00K | 331.00K | 172.00K | 60.00K | 12.00K | -515.00K | 352.00K |
Operating Expenses | 41.49M | 56.68M | 50.33M | 38.21M | 43.63M | 40.19M | 46.49M | 48.09M | 44.46M | 30.80M | 19.96M | 14.67M |
Interest Expense | 5.34M | 6.08M | 6.59M | 5.50M | 7.35M | 6.68M | 8.91M | 4.10M | 1.97M | 721.00K | 403.00K | 154.00K |
Selling & Marketing Expenses | - | 100.00K | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 56.86M | 77.81M | 71.03M | 59.49M | 60.39M | 55.59M | 58.52M | 54.96M | 46.20M | 30.80M | 19.96M | 14.67M |
Income Tax | - | 1.05M | 4.25M | 2.41M | 4.11M | 619.00K | 9.24M | 1.99M | 562.00K | 42.00K | -112.00K | 506.00K |
Shares Outstanding (Basic) | 2.61M | 51.00K | 31.77K | 24.27K | 9.10K | 405.59K | 321.31K | 260.16K | 205.02K | 86.75K | 13.96K | 139.97K |
Shares Outstanding (Diluted) | 2.61M | 51.00K | 31.77K | 24.27K | 9.10K | 405.59K | 321.31K | 260.16K | 205.02K | 86.75K | 13.96K | 139.97K |
EPS (Basic) | -19.19 | -1.24K | -1.68K | -2.03K | -6.93K | -126.12 | -194.29 | -210.66 | -220.91 | -361.85 | -1.48K | -103.27 |
EPS (Diluted) | -19.19 | -1.24K | -1.68K | -2.03K | -6.93K | -126.12 | -194.29 | -210.66 | -220.91 | -361.85 | -1.48K | -103.27 |
EBITDA | -43.88M | -55.20M | -41.13M | -38.49M | -48.30M | -41.96M | -50.58M | -48.43M | -41.86M | -29.98M | -19.62M | -13.73M |
Depreciation & Amortization | 859.00K | 2.27M | 2.54M | 3.16M | 3.64M | 2.45M | 2.94M | 2.28M | 1.47M | 691.00K | 584.00K | 571.00K |